3 Year Absolute Returns
41.61% ↑
NAV (₹) on 15 Sep 2026
31.11
1 Day NAV Change
-1.40%
Risk Level
Very High Risk
Rating
-
Mirae Asset Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Mirae Asset Global Investments (India) Pvt. Ltd.. Launched on 11 Jun 2018, investors can start ... Read more
AUM
₹ 3,555.18 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 75.40% |
| Hospitals & Medical Services | 23.18% |
| Chemicals - Speciality | 0.64% |
| Chemicals - Inorganic - Others | 0.45% |
| Treps/Reverse Repo | 0.44% |
| Mutual Fund Units | 0.01% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.90% | ₹ 387.45 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 9.91% | ₹ 352.34 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 7.06% | ₹ 250.87 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 5.91% | ₹ 210.22 | Hospitals & Medical Services |
| Laurus Labs Ltd. | 5.24% | ₹ 186.28 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 4.99% | ₹ 177.35 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 3.94% | ₹ 140.21 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 3.81% | ₹ 135.53 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 3.43% | ₹ 121.92 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 3.40% | ₹ 120.90 | Hospitals & Medical Services |
| Alkem Laboratories Ltd. | 3.39% | ₹ 120.39 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 3.30% | ₹ 117.41 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 3.16% | ₹ 112.32 | Hospitals & Medical Services |
| Aster DM Quality Care Ltd. | 3.01% | ₹ 106.93 | Hospitals & Medical Services |
| Onesource Specialty Pharma Ltd. | 2.96% | ₹ 105.10 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 2.77% | ₹ 98.37 | Hospitals & Medical Services |
| Cipla Ltd. | 2.71% | ₹ 96.33 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 2.58% | ₹ 91.86 | Hospitals & Medical Services |
| Eris Lifesciences Ltd. | 2.55% | ₹ 90.75 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.44% | ₹ 86.63 | Pharmaceuticals |
| Lupin Ltd. | 2.40% | ₹ 85.38 | Pharmaceuticals |
| Biocon Ltd. | 2.13% | ₹ 75.88 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.13% | ₹ 75.71 | Pharmaceuticals |
| Molbio Diagnostics Ltd. | 1.44% | ₹ 51.36 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 1.13% | ₹ 40 | Pharmaceuticals |
| Symbiotec Pharmalab Ltd. | 0.98% | ₹ 35 | Pharmaceuticals |
| Narayana Hrudayalaya Ltd. | 0.91% | ₹ 32.43 | Hospitals & Medical Services |
| Neogen Chemicals Ltd. | 0.64% | ₹ 22.66 | Chemicals - Speciality |
| Deepak Nitrite Ltd. | 0.45% | ₹ 16.01 | Chemicals - Inorganic - Others |
| TREPS | 0.44% | ₹ 15.74 | Others |
| Mirae Asset Liquid Fund-Direct Plan-Growth | 0.01% | ₹ 0.24 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 10.40% | 8.42% | 0.45% | 12.30% |
| Category returns | 3.34% | 3.85% | 2.63% | 19.22% |
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29 | 18.43% | 142.90% | 0.00% | ₹11,478 | 1.78% |
Very High
|
What is the current NAV of Mirae Asset Healthcare Fund - Direct Plan IDCW?
What is the fund size (AUM) of Mirae Asset Healthcare Fund - Direct Plan IDCW?
What are the historical returns of Mirae Asset Healthcare Fund - Direct Plan IDCW?
What is the risk level of Mirae Asset Healthcare Fund - Direct Plan IDCW?
What is the minimum investment amount for Mirae Asset Healthcare Fund - Direct Plan IDCW?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article